HealthEquity, Inc. (NASDAQ:HQY – Get Free Report) Director Evelyn S. Dilsaver sold 32,500 shares of HealthEquity stock in a transaction dated Tuesday, March 26th. The stock was sold at an average price of $79.29, for a total value of $2,576,925.00. Following the completion of the transaction, the director now owns 32,123 shares of the company’s stock, valued at approximately $2,547,032.67. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
HealthEquity Stock Performance
Shares of NASDAQ HQY traded up $1.91 during trading hours on Thursday, reaching $81.63. The stock had a trading volume of 624,725 shares, compared to its average volume of 607,481. The firm has a 50-day moving average of $79.76 and a 200-day moving average of $73.25. The firm has a market cap of $7.00 billion, a price-to-earnings ratio of 124.56, a PEG ratio of 1.34 and a beta of 0.53. HealthEquity, Inc. has a fifty-two week low of $48.86 and a fifty-two week high of $84.49. The company has a current ratio of 4.76, a quick ratio of 4.93 and a debt-to-equity ratio of 0.43.
Hedge Funds Weigh In On HealthEquity
Large investors have recently modified their holdings of the business. PNC Financial Services Group Inc. increased its stake in HealthEquity by 31.8% in the first quarter. PNC Financial Services Group Inc. now owns 13,547 shares of the company’s stock valued at $913,000 after purchasing an additional 3,266 shares during the last quarter. AlphaCrest Capital Management LLC acquired a new position in shares of HealthEquity during the first quarter worth $234,000. Natixis Advisors L.P. acquired a new position in shares of HealthEquity in the first quarter worth about $932,000. Bank of Montreal Can boosted its stake in shares of HealthEquity by 44.5% during the 1st quarter. Bank of Montreal Can now owns 8,218 shares of the company’s stock valued at $553,000 after buying an additional 2,532 shares during the last quarter. Finally, Rhumbline Advisers increased its position in shares of HealthEquity by 2.2% in the 1st quarter. Rhumbline Advisers now owns 231,307 shares of the company’s stock worth $15,599,000 after purchasing an additional 4,880 shares during the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Read Our Latest Analysis on HQY
HealthEquity Company Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Stories
- Five stocks we like better than HealthEquity
- Compound Interest and Why It Matters When Investing
- 3 Value Stocks Too Small For Buffett’s Portfolio
- Business Services Stocks Investing
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.